Skip to content
VectorGene
en

CHGB · Partner-reported service scope

Proprietary Probiotic Development

Thirteen bacterial strains, some patent-pending, combined with prebiotics for functional products targeting immune regulation, pathogen inhibition and nutrient absorption.

Partner-reported scope
13 strains
Method
A gloved hand holds a culture plate containing microbial growth.
Research sampling

CHGB · Partner-reported

Service capabilities

The following scope is reported by the partner. Quantities describe the partner portfolio and do not represent VectorGene’s own track record.

Immune regulation
Pathogenic inhibition
Including Helicobacter pylori.
Nutrient digestion and absorption

Explore the related platform.

Metagenomic and targeted sequencing platforms for infectious disease diagnosis, outbreak surveillance and microbiome research at institutional or national scale.

Pathogen & Microbiome Sequencing
Varies by jurisdiction

Clinical use of metagenomic sequencing is regulated as a diagnostic and varies by jurisdiction. Surveillance and research applications typically sit under different frameworks.

Explore services in this category.

Read each service’s complete scope and regulatory note. These links help you explore the portfolio; programme-specific suitability requires feasibility assessment.

Assess the strain, formulation and intended claim.

A probiotic development brief should identify the organisms, product format and proposed application. Review evidence for that combination rather than the category as a whole. Manufacturing, stability and permitted claims can then be examined against a defined product and market.

Probiotic effects can differ between microorganisms. Evidence for one strain or use cannot simply be applied to another, and effectiveness and safety remain uncertain for many proposed applications.

NIH NCCIH: Probiotics: Usefulness and Safety

External references explain the wider context. They do not verify or endorse the supplied VectorGene or partner offering.

Questions for the programme brief

  1. Which strain and formulation?

    Request strain identity, access rights, composition and the proposed population and use.

  2. Which claim is supported?

    Review product-specific evidence and distinguish research objectives from claims intended for a commercial label.

  3. What must manufacturing preserve?

    Agree identity, purity, stability and release specifications, plus the responsibilities for ongoing quality review.

What to prepare for review
  • Strain and formulation specification
  • Intended claims and supporting evidence
  • Manufacturing, stability and quality brief

Working environments

Culture and microbial research tools.

Illustrative stock photography provides context for the people, processes and working environments behind this capability.

Test tubes arranged in a blue laboratory rack. Illustrative stock photograph.
Test tubes arranged in a blue laboratory rack
Reagent bottles and labelled laboratory containers. Illustrative stock photograph.
Reagent bottles and labelled laboratory containers
A laboratory workbench with analytical equipment and a microscope.
Laboratory workbench
Clear culture dishes and laboratory glassware.
Culture dishes

Start a conversation

Discuss Proprietary Probiotic Development

This service will be retained as context for your enquiry. Choose the platform or support area you want to develop at your institution.
Partner with us